Effect of extra virgin olive oil on biomarkers of inflammation in HIV-infected patients: A randomized, crossover, controlled clinical trial

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 2406-2413

  Dokmanović, Sanja Kozić ^a   Kolovrat, Krunoslava ^a   Laškaj, Renata ^a   Jukić, Vedrana ^a   Vrkić, Nada ^b   Begovac, Josip ^a,c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Croatia   (Croatia)

Author keywords

Anti HIV agents; Atherosclerosis; Inflammation; Olea

Indexed keywords

ABACAVIR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; EXTRA VIRGIN OLIVE OIL; FIBRINOGEN; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOPINAVIR PLUS RITONAVIR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OLIVE OIL; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; AUTACOID; DRUG COMBINATION; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LOPINAVIR; LOPINAVIR-RITONAVIR DRUG COMBINATION; RITONAVIR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ERYTHROCYTE SEDIMENTATION RATE; EXPLORATORY RESEARCH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFLAMMATION; MALE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD; VISUAL ANALOG SCALE; ADOLESCENT; BLOOD; CLINICAL TRIAL; DIET THERAPY; DRUG COMBINATION; FOOD HANDLING; HIV INFECTIONS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; SINGLE BLIND PROCEDURE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATHEROSCLEROSIS; BIOMARKERS; C-REACTIVE PROTEIN; CROSS-OVER STUDIES; DRUG COMBINATIONS; FOOD HANDLING; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INFLAMMATION MEDIATORS; LOPINAVIR; MALE; MIDDLE AGED; OLIVE OIL; RITONAVIR; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84939506984     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893881     Document Type: Article

References (35)

1. Hasse B, Ledergerber B, Furrer H et al: Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis, 2011; 53: 1130-39
2. Višković K, Rutherford GW, Sudario G et al: Ultrasound measurements of carotid intima-media thickness and plaque in HIV-infected patients on the Mediterranean diet. Croat Med J, 2013; 54: 330-38
3. Zaaqoq AM, Khasawneh FA, Smalligan RD: Cardiovascular complications of HIV-associated immune dysfunction. Cardiol Res Pract, 2015; 2015: 302638
4. Holmberg SD, Moorman AC, Williamson JM et al: Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet, 2002; 360: 1747-48
5. Worm SW, Sabin C, Weber R et al: Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D: A: D) study. J Infect Dis, 2010; 201: 318-30
6. Curtiss LK: Reversing atherosclerosis? N Engl J Med, 2009; 360: 1144-46
7. Mehta N, Reilly M: Atherosclerotic cardiovascular disease risk in the HAARTtreated HIV-1 population. HIV Clin Trials, 2005; 6: 5-24
8. Galescu O, Bhangoo A, Ten S: Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS. Rev Endocr Metab Disord, 2013; 14: 133-40
9. Aberg JA: Aging, Inflammation and HIV infection. Top Antivir Med, 2012; 20: 101-5
10. Begovac J, Dragović G, Višković K et al: Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy. Croat Med J, 2015; 56: 14-23
11. Estruch R, Ros E, Salas-Salvado J et al: PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med, 2013; 368: 1279-90
12. Medina-Remon A, Tresserra-Rimbau A, Pons A et al: Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort. The PREDIMED randomized trial. Nutr Metab Cardiovasc Dis, 2015; 25: 60-67
13. Casas R, Sacanella E, Urpi-Sarda M et al: The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS One, 2014; 9: e100084
14. Mierzecki A, Kłoda K, Bukowska H et al: Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors. Med Sci Monit, 2013; 19: 733-39
15. Covas MI, Ruiz-Gutierrez V, de la Torre R et al: Olive oil minor components: evidence to date of health benefits in humans. Nutr Rev, 2006; 64: s20-30
16. Fito M, Cladellas M, de la Torre R et al: Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: A randomized, crossover, controlled, clinical trial. Atherosclerosis, 2005; 181: 149-58
17. Covas MI, Nyyssonen K, Poulsen HE et al, EUROLIVE Study Group: The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med, 2006; 145: 333-41
18. Toledo E, Hu FB, Estruch R et al: Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med, 2013; 11: 207
19. Tanaka T, Kishimoto T: The biology and medical implications of interleukin-6. Cancer Immunol Res, 2014; 2: 288-94
20. Zimmermann O, Li K, Zaczkiewicz M et al: C-Reactive protein in human atherogenesis: facts and fiction. Mediators Inflamm, 2014; 2014: 561428
21. Fukai T, Ushio-Fukai M: Superoxide dismutases: role in redox signaling, vascular function and diseases. Antioxid Redox Signal, 2011; 15: 1583-606
22. Wang X, Pu H, Ma C et al: Adiponectin abates atherosclerosis by reducing oxidative stress. Med Sci Monit, 2014; 20: 1792-800
23. Ho E, Karimi Galougahi K, Liu CC et al: Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox Biol, 2013; 1: 483-91
24. Fito M, Cladellas M, de la Torre R H et al: SOLOS Investigators. Antiinflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial. Eur J Clin Nutr, 2008; 62: 570-74
25. Massela R, Vari R, D'Archivio M et al: Extra virgin olive oil phenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr, 2004; 134: 785-91
26. Martinez-Gonzalez MA, Corella D, Salas-Salvado J et al: Cohort profile: design and methods of the PREDIMED study. Int J Epidemiol, 2012; 41(2): 377-85
27. Salas-Salvado J, Garcia-Arellano A, Estruch R et al, PREDIMED Investigators: Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur J Clin Nutr, 2008; 62: 651-59
28. Singleton VL, Orthofer R, Lamuela-Raventos RM: Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin & Ciocalteau reagent. Methods in Enzymology, 1999; 299: 152-78
29. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med, 1976; 15: 212-16
30. Perović Mihanović M, Haque NS, Rutherford GW et al: Toxicity-related antiretroviral drug treatment modifications in individuals starting therapy: A cohort analysis of time patterns, sex, and other risk factors. Med Sci Monit, 2013; 19: 483-92
31. da Silva EF, Barbaro G: New options in the treatment of lipid disorders in HIV-infected patients. Open AIDS J, 2009; 3: 31-37
32. Madden E, Lee G, Kotler DP et al: Association of antiretroviral therapy with fibrinogen levels in HIV-infection. AIDS, 2008; 22: 707-15
33. Miro-Casas E, Farre Albaladejo M, Covas MI et al: Capillary gas chromatography- mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake. Anal Biochem, 2001; 294: 63-72
34. Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L et al: Consensus report, Jaen (Spain). International conference on the healthy effect of virgin olive oil. Eur J Clin Invest, 2005; 35: 421-24
35. Vissers MN, Zock PL, Katan MB: Bioavailability and antioxidant effects of olive phenols in humans: a review. Eur J Clin Nutr, 2004; 58: 955-65